Genolution Inc (225220)

Currency in KRW
1,171
+55(+4.93%)
Delayed Data·
225220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,0941,186
52 wk Range
9572,830
Key Statistics
Bid/Ask
1,163.00 / 1,171.00
Prev. Close
1,116
Open
1,116
Day's Range
1,094-1,186
52 wk Range
957-2,830
Volume
56.07K
Average Volume (3m)
117.06K
1-Year Change
-49.8501%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
225220 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 15, 2026
EPS / Forecast
33.00 / --
Revenue / Forecast
2.49B / --
EPS Revisions
Last 90 days

225220 Income Statement

Compare 225220 to Peers and Sector

Metrics to compare
225220
Peers
Sector
Relationship
P/E Ratio
−2.2x12.3x−0.4x
PEG Ratio
8.000.020.00
Price/Book
0.3x1.1x2.6x
Price / LTM Sales
2.1x2.1x3.0x
Upside (Analyst Target)
-45.1%57.0%
Fair Value Upside
Unlock9.6%9.1%Unlock

Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products. Genolution Inc. was founded in 2006 and is based in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.65M9.11%1.84B
Public Companies & Retail Investors
16.42M90.89%18.33B
Total
18.07M100.00%20.16B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
HoilBioMed Co., Ltd.6.16%1,112,7401,241,818
Genex Co., Ltd.1.52%275,038306,942

FAQ

What Is the Genolution (225220) Stock Price Today?

The Genolution stock price today is 1,171 KRW.

What Stock Exchange Does Genolution Trade On?

Genolution is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Genolution?

The stock symbol for Genolution is "225220."

What Is the Genolution Market Cap?

As of today, Genolution market cap is 20.16B KRW.

What Is Genolution's Earnings Per Share (TTM)?

The Genolution EPS (TTM) is -496.

When Is the Next Genolution Earnings Date?

Genolution will release its next earnings report on Aug 19, 2026.

From a Technical Analysis Perspective, Is 225220 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genolution Stock Split?

Genolution has split 3 times.

How Many Employees Does Genolution Have?

Genolution has 75 employees.

What is the current trading status of Genolution (225220)?

As of Jun 29, 2026, Genolution (225220) is trading at a price of 1,171 KRW, with a previous close of 1,116 KRW. The stock has fluctuated within a day range of 1,094 KRW to 1,186 KRW, while its 52-week range spans from 957 KRW to 2,830 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.